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The regulation of the IgE immune response has been shown to be dependent 
upon  the  dose  of the  antigen  employed for  the  induction  of the  primary 
response (1) as well as during secondary antigenic stimulation (2-5), persistent 
IgE responses being favored by low doses of antigen.  Takatsu and Ishizaka, 
utilizing passive transfer experiments in mice, demonstrated that high doses of 
antigen prevented the development of antigen-specific IgE bone marrow-derived 
lymphocytes (B cells) 1  in the spleens of the treated mice (3), caused a decreased 
carrier-specific helper activity of the thymus-derived lymphocyte (T cells) in 
the spleens (4), and that these effects were due to the induction of T suppressor 
cells by the high doses of antigen (5). 
Maia et al.  (2), on the other hand, postulated that IgE B cells can be made 
tolerant by the administration of high doses of antigen, and concluded that the 
differential susceptibility to antigen-induced suppression of IgE and IgG anti- 
body responses was due to the fact that IgE B  cells were more easily made 
tolerant than IgG B cells. Results of experiments reported by Lee and Sehon 
(6-8) supported that concept. 
It  has  been  well  documented that  the  IgE  antibody response  is  under a 
strong T-lymphocyte influence. Induction of an IgE response in mice requires 
the  participation  of T  cells  (9). Katz  et  al.  (10) demonstrated that  the  IgE 
antibody response by B cells is more dependent on specific helper signals from 
T lymphocytes than IgG B cells. The ongoing IgE response is more sensitive to 
suppressor T-cell signals as a result of an increased susceptibility of IgE B cells 
to T-cell signals, as proposed by Katz et al.  (10), or an increased susceptibility 
of the IgE T  helper lymphocytes to T  suppressor-cell signals,  as proposed by 
Takatsu and Ishizaka (5). 
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A  great deal of information has been obtained utilizing in vitro systems for 
studying the regulation of antibody production. The studies presented in this 
paper were designed to examine the regulation of the IgE immune response in 
vitro. In particular, we wished to study the role of antigen in the regulation of 
IgE antibody formation,  to define the cellular site of such regulation,  and to 
compare the IgE antibody response in vitro to the response in other immuno- 
globulin classes of antibody. 
Materials and Methods 
Animals.  Female CBA/J, AKR/J, C3H/HeJ, and HRS/J  (hairless) mice (6-10 wk old) were 
purchased from The Jackson Laboratory,  Bar Harbor, Maine. 
Antigens.  Hen egg albumin (EA), crystallized five times, and bovine gamma globulin (BGG), 
Fr II, were purchased from Miles Laboratories, Inc., Elkhart, Ind. 
The sodium salt of 2,4-dinitrobenzene  sulfonic acid  (Eastman  Kodak Co.,  Rochester,  N.  Y.) 
was used to couple dinitrophenyl  (DNP) haptenic groups to EA and BGG (11).  After extensive 
dialysis  against  distilled  water,  the  molar  ratios  of DNP  to  protein  of the  conjugates  were 
determined spectrophotometrically and found to be 3.2 DNP:I EA and 56 DNP:I BGG. 
Mitogens.  Lipopolysaccharide  W  (LPS) from Escherichia coil O127:B8,  obtained from Difco 
Laboratories,  Detroit,  Mich., was dissolved in saline and placed in a  boiling water bath for 30 
min before use.  Purified  concanavalin  A  (Con  A) was the  gift of Dr.  D.  Behnke's laboratory 
(Department of Biochemistry, University of Cincinnati, Cincinnati, Ohio). 
Immunization.  All mice were immunized by intraperitoneal injection (i.p.) with EA or DNP- 
EA in aluminum hydroxide gel which had been prepared by the method of Levine and Vaz (1). 
Antigen doses were as described in the figure legends. 
Cell Culture Systems.  Spleens from mice were removed aseptically and made into single cell 
suspensions  by pressing through 80-mesh stainless steel screens into Eagle's Minimal Essential 
Medium  (MEM; Grand  Island Biological Co.,  Grand  Island,  N.  Y.),  prepared  as described by 
Mishell and  Dutton  (12),  and  supplemented  with  penicillin  (100 U/ml) and  streptomycin  (100 
~g/ml). The resulting cell suspensions  were washed once and resuspended in the MEM supple- 
mented with 10% fetal calf serum (FCS; Rehatuin, lot M18310,  Reheis Chemical Co., New York). 
The cells were adjusted to 1.8-2.2  x  107 viable cells/ml, as determined by trypan dye exclusion, 
and  1-ml aliquots were placed  in 35-mm plastic  tissue culture dishes  (Falcon Plastics,  Div. of 
BioQuest,  Oxnard,  Calif.)  for  culturing  under  Mishell-Dutton  tissue  culture  conditions,  as 
described previously (13). 
Cellular  proliferation  in  vitro  was  measured  by  assessing  the  incorporation  of  tritiated 
{3H]thymidine  (New England Nuclear,  Boston,  Mass.) by spleen cells stimulated with LPS (10 
#g)  or  Con  A  (2  /~g). These  concentrations  of mitogens  were  found  to be  optimal  under  the 
experimental conditions employed. Spleen cells, or subpepulations of spleen cells, were adjusted 
to 4  x  10  ~ viable cells/ml RPMI 1640 medium (Grand Island Biological Co.), supplemented with 
5% heat-inactivated  (56°C,  30  rain)  FCS.  Cells were cultured in triplicate  in 0.5-ml aliquots in 
plastic tissue culture tubes (model 2058; Falcon Plastics) in a humidified COs incubator (37°C). At 
the end of 24 h, each culture received 1 ~Ci [3H]thymidine, and culturing was continued for an- 
other 16 h.  Cells were harvested for counting 3H, as described previously (13). 
Cell Separation Techniques.  Spleen cells were enriched for B cells by incubating them for 30 
min at room temperature  in a  1:10 dilution of anti-0  serum  (prepared by injecting AKR/J mice 
weekly for 10 wk, i.p., with l0  s thymocytes taken from C3H/HeJ mice), followed by incubation at 
37°C in the presence of sterile guinea pig complement (C'; Microbiological Associates, Bethesda, 
Md.).  The optimal ratio of anti~  serum to spleen cells for killing T  cells had been determined 
previously by determining the optimal ratio for killing thymocytes. 
The nylon wool technique, originally described by Julius et al.  (14),  as modified by Schwartz 
et al.  (15), was used to obtain a splenic lymphocyte preparation depleted of adherent cells and B 
cells and thus enriched for T cells. 
Spleen  cells  were  separated  into  an  adherent  (A) cell  population  (presumed  to  be  mainly 
macrophages)  and  a  nonadherent  (NA) cell population  by allowing A  cells to attach  to plastic 
tissue culture dishes as described by Mosier (16). 1-ml aliquots of spleen cell suspensions (1.8-2.2 1536  REGULATION  OF  REAGINIC  ANTIBODY  PRODUCTION  IN  MICE 
×  107/mt) were placed in the tissue culture dishes and incubated at 37°C  for 30 rain in a  plastic 
box,  charged with a  three-gas mixture  (13),  placed on a  rocking platform  (10 oscillations per 
rain). The NA cell population was that removable by gentle washing of the bottom of the Petri 
dish. The A cell population was that which remained attached after two 1-ml washes with MEM, 
and was quantitated by counting 10 microscope fields of known area and extrapolating to the 
number of A  cells/dish. The percentage of macrophages in the A  and NA cell populations was 
determined by assessing phagocytosis of neutral red (17). 
Antibody Assay Methods.  Reaginic (IgE) antibody titers were determined by injecting 0.05- 
ml  aliquots of twofold dilutions of cell cultures or  supernates  of cell cultures  into the skin of 
HRS/J mice. Anti-EA and anti-DNP IgE titers were measured by challenging recipient mice 24 h 
later with EA (1 mg) or DNP-BGG (100  /~g), respectively,  in Evans blue dye  (18).  It was found 
that the antibodies detected by this technique were heat-labile (56°C,  4 h), long-term sensitizing, 
and thus, classifiable as mouse IgE (19).  IgE titers were found not to vary by more than twofold, 
and unless indicated by standard error, a  greater than twofold difference in titers is considered 
to be significant. 
Anti-DNP IgM and IgG production in vitro was determined by the plaque-forming cell (PFC) 
assay,  originally described by Jerne and Nordin  (20),  as modified by Rittenberg and Pratt  (21) 
with trinitrophenol (TNP)-coated sheep erythrocytes. The cross-reactivity of anti-DNP antibodies 
with  TNP  has  been  demonstrated  previously  by  others  (22).  Rabbit  antimouse  IgG  (Miles 
Laboratories Inc.) diluted 1:100 in medium 199 (m199, Grand Island Biological Co.),  was used to 
facilitate anti-DNP indirect (IgG) PFCs. 
Results 
Anti-DNP IgE Production In Vitro.  To differentiate more clearly cell types 
involved in antibody regulation,  we employed a  hapten-carrier  system, DNP- 
EA antigen,  in our priming regimen. 
Two priming doses (1 or 100 ~g DNP-EA in 1 mg AI[OH]3 gel) were examined 
to determine which schedule would allow the greater production of anti-DNP 
IgE in vitro.  11 days after primary immunization,  the time of peak anti-DNP 
IgE production in CBA/J mice, was chosen as the point at which spleen cells 
would receive secondary antigenic challenge in vitro. The kinetics of anti-DNP 
IgE production in vitro by spleen cells cultured in the absence of antigen  are 
shown in Fig. 1. Spleen cells from the mice primed in vivo with 1 ~g DNP-EA 
produced higher  titers of anti-DNP  IgE  (1:32) than did spleen cells from mice 
primed  with  100  ~g  DNP-EA  (1:4  peak  titer).  Peak  antibody  titers  were 
observed after 4-5 days of culturing. 
The production of anti-DNP IgE antibody by primed spleen cells cultured in 
the presence of DNP-EA is shown in Fig.  2.  The amount of antibody detected 
decreased sharply as the concentration of DNP-EA in the culture was increased 
from  1  ×  10  -4 to  1  ×  10  -1  ~g/ml.  The kinetics  of IgE  production by cultures 
stimulated  with  exogenous  antigen  were  not  altered,  i.e.,  peak  titers  were 
detectable from day 3 to day 5 regardless of DNP-EA concentration. 
It was found that the titers of anti-DNP IgE antibody in the supernates of 4- 
and 5-day tissue cultures were identical to the IgE titers of the whole cultures 
(including  lymphocytes).  In  addition,  the  IgE  antibody  detected by injecting 
supernates  for  passive  cutaneous  anaphylaxis  (PCA)  determinations  was 
equally as heat-labile as the IgE detected by injecting whole spleen cell cultures. 
Therefore,  in all  subsequent experiments,  whole cultures  were used to  assay 
for anti-DNP IgE. 
Test for Neutralization  of Anti-DNP IgE  by Antigen  In  Vitro.  The  next PAMELA  JONES  DANNEMAN  AND  J.  GABRIEL  MICHAEL  1537 
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FIG.  1.  Kinetics of antihapten  in vitro IgE production by spleen cells from CBA/J mice 
immunized with 1/~g (O--O) or 100 ~g (O--Q) DNP-EA in AI(OH)3 gel. After 11 days, the 
spleen cells were placed in tissue culture in the absence of exogenous antigen. Triplicate 
cultures were harvested after 4 and 5 days in vitro and assayed in duplicate HRS/J mice 
for the presence of anti-DNP IgE by 24-h passive cutaneous anaphylaxis (PCA). Challenge 
antigen for the PCA test was DNP-BGG. 
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FIG.  2.  Effect of adding antigen on production of anti-DNP IgE in tissue culture. Spleen 
cells from mice immunized 11 days earlier with 1/~g DNP-EA in AI(OH)3 gel were placed 
in tissue culture on day 0 and were cultured without antigen (O--O) or in the presence of 
1 x  10  -4 (A--A), 1 x  10 -3 ([~--D), 1 x  10 -2 (Q---S), or 1 x  10 -1 (D---I) ~g DNP-EA. IgE 
titers shown represent the £ log~ heat-labile anti-DNP antibody titers of duplicate cultures 
assayed by 24-h PCA in duplicate HRS/J mice at the times indicated. 1538  REGULATION  OF  REAGINIC  ANTIBODY  PRODUCTION  IN  MICE 
TABLE I 
Test for Neutralization of Anti-DNP Serum IgE by Antigen In Vitro 
Antigen added  ~g/ml 
Anti-DNP IgE titer after 5 days incubation in 
vitro 
Serum  + 2  x  107 non- 
Serum,  no cells* 
immune spleen cells* 
None  0  5.0  +_  0.635  5.2  +_  0.41 
DNP-EA  1  x  10  -~  5.3  +-  0.52  4.3  +_  1.86 
1  x  10 -4  5.3  -+  0.52  5.0  _+  0.89 
1  x  I0 3  5.3  -+  0.52  5.0  -+  0.89 
1  x  10  -2  5.5  +-  0.55  4.8  _+  0.75 
1  x  I0-'  5,2  ~  0.75  5,0  -+  0.63 
DNP-BGG  1  x  10  ~  5.2  _+  0.75  5.3  +_  0.52 
1  x  10 -~  4.8  _+  0.75  5.0  -+  0.63 
1  x  10 -3  4.7  _+  0.82  4.7  +_  0.82 
1  x  10  -2  5.3  _+  0.52  4.8  _+  0.41 
1  x  10-'  5.0  -  0.63  5.0  _+  0.63 
EA  1  ×  10 -~  5.2  _+  0.75  5.2  _+  0.41 
* Anti-DNP serum diluted in MEM  +  10% FCS to PCA titer of approximately 
in triplicate under standard tissue culture conditions. 
$ ~  Logz (+-  SEM), based on triplicate cultures assayed in duplicate. 
2%then cultured 
experiment was designed to determine whether the concentrations  of antigen 
to  be  employed  in  in  vitro  experiments  neutralized  anti-DNP  IgE.  Hapten 
coupled  to  homologous  carrier  (DNP-EA),  hapten  coupled  to  heterologous 
carrier  (DNP-BGG), or carrier  alone (EA) were added on day 0 at appropriate 
concentrations  to  cultures  containing  mouse  serum  anti-DNP  IgE  antibody 
(diluted to 1:16-1:32,  a  titer  approximating  the maximum  anti-DNP IgE titer 
attainable  in  tissue  culture)  alone  or  in  the  presence  of  2  x  107  normal 
(nonimmune)  CBA/J splenic lymphocytes. The  residual  anti-DNP  IgE  titers, 
after 5 days of incubation under standard tissue culture conditions,  are shown 
in Table  I.  None of the  antigen  (hapten  and/or carrier)  concentrations  tested 
resulted  in  neutralization  of the  anti-DNP  IgE  antibodies.  In  addition,  the 
presence of splenic lymphocytes did not alter survival or neutralization patterns 
of the  IgE.  Tissue-culture-produced  IgE  (in the EA in vitro system, data not 
presented)  also  showed  a  lack  of neutralization  by  EA  until  the  antigen 
concentration was ---5 x  10-'  ~g/ml. 
Test for Inhibition of Anti-DNP IgE Production by Hapten and~or Carrier In 
Vitro.  The results of the preceding experiment indicated that any decrease in 
IgE production in vitro induced by antigen concentrations up to and including 
1  x  10  -' ~g/ml could not be attributed to neutralization.  In the next experiment, 
the  ability of hapten  or carrier  alone to  induce  inhibition  of antihapten  IgE 
production was examined. 
As  shown  in  Fig.  3,  maximum  IgE  production  occurred  in  the  absence  of 
exogenous  antigens.  Hapten,  whether  coupled to  homologous  carrier  (DNP- 
EA) or heterologous carrier  (DNP-BGG) suppressed anti-DNP IgE production, PAMELA  JONES  DANNEMAN  AND  J. GABRIEL  MICHAEL  1539 
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FIG. 3.  Inhibition of in vitro IgE production by antigen. Spleen cells from mice immunized 
11  days earlier with  1 /lg DNP-EA  plus AI(OH)~ gel were cultured  for 5 days in the 
presence of DNP-EA (0--0),  DNP-BGG  (l~--~),  or EA  (I--B).  Anti-DNP IgE titers 
shown represent the £ log2, based on duplicate cultures assayed in duplicate. 
TABLE  I[ 
Separation of Spleen Cells into B-Cell-Enriched or T-CeU-Enriched 
Populations 
Experiment 
Anti-8  + C' sen- 
sitivity  of  whole 
spleen 
(% lymphocytes 
killed) 
1  32 
2  24 
3  29 
Nylon wool effluent 
Nonadherent 
Spleen cells non-  cells killed by 
adherent  anti-8 + C' 
%  % 
13  85 
8  90 
12.5  95 
whereas  carrier  (EA) alone had no enhancing  or suppressing effect on anti- 
DNP  IgE production in vitro. 
Role  of T  Lymphocytes  in  Antihapten  IgE  Production  or  Suppression  In 
Vitro.  The contribution  made by T  cells to the  production of hapten-induced 
inhibition of IgE production in vitro was next investigated. 
Spleen  cells  from  primed  mice  were  depleted  of T  cells  by  anti-0  plus  C' 
treatment  (B cell enriched)  or enriched for T  cells by nylon wool passage.  As 
shown  in  Table  II,  anti-0  +  C'-sensitive spleen  cells  accounted  for 29-34%  of 
the  CBA/J spleen cell population.  The yield of cells from nylon wool columns 
ranged  from 8  to  13%  of the  whole  spleen,  and  the  anti-0  +  C'  sensitivity of 
this T  cell-enriched population was found to be 85-95%. 
In control experiments, whole or enriched spleen cell populations were tested 
for their proliferative response  ([3H]thymidine  incorporation)  in vitro to mito- 
genic stimulation by 10/~g LPS,  a  B-cell mitogen, and to 2  fig Con A, a  T-cell 
mitogen.  The mean counts per minute  (cpm)  _+  standard  error  [3H]thymidine 
incorporated  were  as follows  (background  cpm subtracted).  Whole  spleen cell 
cultures  were stimulated by both the LPS (228,765  _+  914 cpm) and the Con A 
(272,459  _+  8,236  cpm).  The  B  cell-enriched  population  responded  well to LPS 
(243,805  _  1,680 cpm) but poorly to Con A  (-8,191  +_ 1,730 cpm), whereas the T 1540  REGULATION  OF REAGINIC  ANTIBODY  PRODUCTION IN MICE 
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FIG. 4.  Effect  of T-cell  depletion  on  hapten-induced  inhibition  of IgE  production  by 
spleen cells. Spleen cells from mice immunized 11 days earlier with 1 ~g DNP-EA + 1 mg 
Al(OH)a gel  were  incubated  without  treatment  (©--©),  after  anti-~  +  C'  treatment 
(D--D), and reconstitution of anti-8  +  C'-treated spleen  cells with nylon wool effluent 
cells (A--A). The anti-DNP IgE titers of the cells cultured for 5 days in the presence  of 
DNP-EA (panel A), DNP-BGG (panel B), or EA (panel C) are shown. 
cell-enriched  population  responded  minimally to  LPS  (22,557  _  351  cpm) but 
gave a  good proliferative response to Con A  (274,956  _  16,670 cpm). 
The anti-DNP IgE antibody production by primed whole spleen cell popula- 
tions,  B  cell-enriched  (anti-O  +  C'-treated  spleen),  or  B  cell-enriched  primed 
spleen cells reconstituted  with T  cell-enriched primed spleen cells (nylon wool 
effluent)  was determined after 5 days of culturing  in vitro.  Results of the IgE 
determinations  from two separate experiments were combined and are shown 
in Fig. 4.  The magnitude of the anti-DNP IgE response by "B" cells or "B +  T" 
cells  cultured  in  the  absence  of  exogenous  antigen  was  not  significantly 
different  (~ log2 titers were 3.5) from that by the whole spleen cell population 
(i log2 titer was 4.0).  In addition,  the  pattern of hapten-induced  inhibition  of 
anti-DNP IgE production was essentially the same for all three cell populations. 
Role of  A  Cells in the Production and Inhibition of  Anti-DNP IgE In Vitro.  A 
cells  have  been  shown  to  play  an  important  role  in  immune  responses  by 
murine splenic lymphocytes in vitro (23-25).  To determine the role of A  cells in PAMELA  JONES  DANNEMAN  AND  J.  GABRIEL  MICHAEL  1541 
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FIG. 5.  Effect  of depletion of A cells on hapten-induced inhibition of IgE production by 
spleen cells in vitro. Whole spleen cells (O--O) or A-cell depleted spleen cells (~--4}) were 
cultured for 5 days in vitro with DNP-EA (panel A), DNP-BGG  (panel B), or EA (panel C). 
Anti-DNP IgE titers are based on the ~ log2 of duplicate cultures assayed in duplicate by 
24-h PCA. 
the production or inhibition of anti-DNP IgE antibody in vitro, primed spleen 
cells were depleted of A  cells  (16)  and cultured for 5  days in the  absence or 
presence of DNP-EA,  DNP-BGG,  or EA.  Under the  conditions employed for 
depleting spleen cells of A cells, it was found that an average of 7.3  x  105 out of 
2.2  ×  107  (3.3%)  spleen cells were adherent,  and of these A  cells,  an average 
80% of them were phagocytic (17). The NA cell population was found to contain 
less than 0.1% phagocytic cells. 
In two separate experiments, whose results were averaged and are shown in 
Fig. 5,  it was found that anti-DNP IgE production by NA cells was essentially 
the same as that by the whole spleen cell population. Maximum IgE production 
was observed in cultures that received no exogenous antigen, and both DNP- 
EA and DNP-BGG but not EA inhibited antihapten IgE production in NA cell 
cultures. 
Secondary  Antihapten IgM and IgG Responses  In  Vitro.  Results  of the 
preceding  experiments  all  pointed  to  a  direct  effect by  hapten  on  the  IgE 
antibody-producing B  cells.  The next experiments were designed to examine 
the  production  of other  classes  of antihapten  antibody  under  conditions  of 
secondary antigen stimulation in vitro. 
The  results  shown  in  Fig.  6  represent the  secondary anti-DNP  IgM  PFC 
response aider 5 days in vitro by spleen cells from mice primed 11 days earlier 1542  REGULATION  OF  REAGINIC  ANTIBODY  PRODUCTION  IN  MICE 
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FIG. 6.  Secondary  anti-DNP PFC response in vitro. Spleen cells from CBA/J mice primed 
11 days earlier with 1 ~g DNP-EA + AI(OH)3 gel (©--©) or from nonimmune control mice 
(@---0) were cultured for 5 days in the presence of DNP-EA (panel A), DNP-BGG (panel 
B), or EA (panel C). The number of direct (IgM) PFCs per 108 viable lymphocytes was 
determined for duplicate cultures assayed in duplicate. The results shown represent the 
± SEM of two separate experiments. 
with 1 tzg DNP-EA in 1 mg AI(OH)s gel. Also shown for purposes of comparison 
are  the  primary  anti-DNP  PFC  response  by  spleen  cells  from  nonimmune 
mice.  Significant secondary IgM  PFC  responses were obtained when primed 
spleen cells were cultured in vitro with homologous hapten-carrier (DNP-EA) 
or carrier (EA) alone, but not when cultured in the presence of hapten coupled 
to heterologous carrier (DNP-BGG). In contrast to these results, DNP-BGG as 
well as DNP-EA (but not EA alone) stimulated a primary hapten-specific IgM 
PFC response by nonprimed splenic lymphocytes in vitro. The anti-DNP IgE 
antibody production and  inhibition of production by primed spleen cells was 
essentially identical to that of previous experiments (Fig.  5)  and is therefore 
not shown. 
The DNP-EA primed lymphocytes in this  experiment did not produce IgG 
PFCs,  as  determined by  the  indirect PFC  assay  (21).  Subsequently,  splenic 
lymphocytes were harvested from mice  21  days  after primary immunization 
with 1 /zg DNP-EA in Al(OH)~ gel. The anti-DNP IgM and IgG PFC responses 
by the  spleen cells cultured for 5 days in vitro are shown in Fig.  7,  and the 
anti-DNP IgE antibody responses by the cultures are shown in Fig. 8. 
The  results  shown  in  Fig.  7  indicate  that  the  secondary antihapten  IgG 
antibody response was enhanced by homologous hapten-carrier (DNP-EA) and 
carrier (EA) alone. In addition, the IgG response was not enhanced by hapten PAMELA  JONES  DANNEMAN  AND  J.  GABRIEL  MICHAEL  1543 
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FIG. 7.  Secondary anti-DNP IgM and IgG PFC responses in vitro. Spleen cells from mice 
immunized 21 days earlier with 1 ~g DNP-EA + AI(OH)3 gel were cultured for 5 days, and 
the  numbers  of  IgM  (O--O)  and  IgG  (O---O)  PFCs  per  108  viable  lymphocytes  were 
determined.  The number of IgG PFCs was calculated by subtracting the number of direct 
PFCs from the number  of indirect  (facilitated by incubating with rabbit antimouse  IgG) 
PFCs.  The  results  shown  represent  the  ~  (_+  SEM) PFC responses  of duplicate  cultures 
assayed in duplicate,  from two different experiments. 
coupled to heterologous carrier, confirming the carrier-related specificity of the 
secondary IgG response in vitro. 
The  anti-DNP  IgE  responses by  spleen  cell  cultures  from mice  primed  21 
days  in  vivo,  on  the  other  hand,  were  suppressed  by  hapten,  whether  on 
homologous (DNP-EA) or heterologous (DNP-BGG) carrier (Fig.  8). 
Discussion 
The results of the present studies reveal that primed mouse IgE B  cells are 
suppressed  by  antigen  under  conditions  of in  vitro  exposure.  The  in  vivo 
priming of mice induced a  population of splenic lymphocytes which produced 
specific  IgE  antibody  after  4-5  days  of in  vitro  culturing.  The  addition  of 
minute amounts of antigen (10-4-10  -l  ~g) to the lymphocyte cultures resulted 
in  suppression  of such  "spontaneous"  IgE  production.  The  suppression was 
found not to be the result of neutralization of antibody by antigen. 1544  REGULATION  OF  REAGINIC  ANTIBODY  PRODUCTION  IN  MICE 
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FIG.  8.  In vitro anti-DNP IgE responses by spleen cells from mice immunized 21 days in 
vivo. Spleen cells from mice immunized with 1 ~g DNP-EA  +  AI(OH)3 gel were cultured 
for  5  days  in  vitro  with  DNP-EA  (O--©),  DNP-BGG  (A--A),  or  EA  (D--D).  Results 
represent the f¢ IgE titers of duplicate cultures assayed in duplicate from the two different 
experiments for which PFC responses are shown in Fig. 7. 
Antigen-induced  regulation  of the  reaginic  antibody response  in  mice  has 
been shown or postulated to occur in two ways: (a) directly at the B-cell level 
(2, 7, 26),  and (b) indirectly, through helper or suppressor T cells (3-5,  10). By 
analyzing the anti-DNP IgE response by the primed lymphocytes to secondary 
stimulation by hapten coupled to homologous carrier (DNP-EA), hapten coupled 
to heterologous carrier  (DNP-BGG), and carrier  (EA) alone, we demonstrated 
that  the  antigen-induced  inhibition  of IgE  production  was  caused by hapten 
and not by carrier.  Our results suggest that the suppression by hapten of the in 
vitro IgE production was the result of a  direct B-cell effect. 
Production of IgE antibodies in vivo has been shown to be sensitive to T-cell 
regulation  (3,  10,  27),  and therefore  it was  decided to  examine  the  role of T 
cells  in  the  production  or  suppression  of anti-DNP  IgE  in  our  experimental 
system. Neither the spontaneous in vitro production of anti-DNP IgE nor the 
hapten-induced suppression of such antibody production was affected by deplet- 
ing  spleen  cell cultures  of T  cells by treatment  with  anti-0  plus  C'.  Thus,  T 
cells were not required for the maximum production of anti-DNP IgE by spleen 
cells primed  11 days earlier in vivo. IgE  production in vitro by B cells at this 
stage  of differentiation  has  not previously been studied by others.  Okudaira 
and Ishizaka  (28) reported that IgE B cells tend to lose their T-cell dependency 
if placed in tissue culture for 24-48 h  before transfer into irradiated  recipient 
mice, and it is possible that the milieu afforded by our tissue culture conditions 
was similar to that offered by an irradiated recipient. 
Macrophages  (A cells) have been shown by others to be involved in antigen- 
induced  suppression  of  immune  responses  (24,  25,  29),  and  therefore  the 
possibility that these cells were involved in the hapten-induced  suppression of 
IgE  was  examined.  The  depletion  of primed  spleen  cultures  of A  cells  was PAMELA  JONES  DANNEMAN  AND  J.  GABRIEL  MICHAEL  1545 
found  to  have  no  effect  on  the  production  of,  or  on  the  hapten-induced 
suppression  of,  anti-DNP  IgE  in  vitro.  Ishizaka  and  Kishimoto  (30),  using 
mesenteric lymph node cells from antigen-primed  rabbits and culturing them 
in vitro, also reported that A cells had no effect on IgE antibody production in 
vitro• 
Although it is not certain that all macrophages or T cells had been removed 
from the spleen cell cultures,  a  drastic reduction in the numbers of these cell 
populations was accomplished and this did not affect the suppressive effects of 
hapten  on  IgE  production.  These  results,  taken  together  with  the  lack  of 
carrier  effect, lead us to conclude that the hapten was interacting  directly at 
the level of the IgE-producing B cell, resulting in a state of nonresponsiveness. 
Such IgE B-cell tolerance in mice in vivo has been reported by Lee and Sehon 
(6-8) using  DNP coupled to mouse T-globulin  (DNP-MTG).  Although  in their 
system,  tolerance  was presumably  due to  the  lack of carrier-specific  T  cells, 
they found that anti-DNP IgE B cells were made tolerant more easily (i.e.,  at 
lower  doses  of DNP-MTG)  than  anti-DNP  IgG  B  cells.  Lee  and  Sehon  (7) 
• speculated  that  the  hapten-specific  tolerance  induced  in  mice  by treatment 
with DNPs-MTG involved the elimination or inactivation of hapten-specific IgE 
B cells, or to the blockade of the receptors of IgE B cells. A similar mechanism 
seems  to  be  operating  in  the  hapten-induced  suppression  of anti-DNP  IgE 
production in vitro reported in the present study, even though an immunogenic 
carrier  (EA) was used. 
Under the priming  and tissue culture conditions of our experiments,  it was 
found  that  the  optimal  concentrations  of antigen  required  for  secondary re- 
sponses  in  vitro  were  similar  for  the  IgM  and  IgG  classes  of  antibody. 
Concentrations  optimal  for IgG and  IgM responses caused suppression of the 
IgE  response.  Carrier  alone  enhanced  antihapten  IgM  and  IgG  antibody 
responses in vitro,  confirming the reports of Kimoto et al.  (31) and Kishimoto 
and Ishizaka (32). In our studies, carrier alone neither enhanced nor suppressed 
the IgE  response.  Our priming  regimen,  which was required  for in vitro IgE 
antibody formation, differed from that employed by Kimoto et al.  (31) who used 
spleen  cell  cultures  from  mice  primed  with  three  doses  of antigen  (1  ~g) 
injected at 4-wk intervals.  It can be assumed that  Kimoto et al.  established a 
true  anamnestic  IgE  response  in  vitro,  which  was  subject to  carrier  (T cell) 
enhancement or suppression.  In our study, in which cultures were established 
U  days  after  a  single  primary  immunization,  either  the  IgE  B  cells  were 
refractory to T-cell signals or T cells present in our cultures were not present 
in high enough numbers or did not possess the capacity to suppress or enhance 
the production of IgE by B cells in vitro. 
It has been shown that antibody specific for an antigen can regulate further 
production  of that  antibody.  This  process,  called  antibody-mediated feedback 
inhibition  (33), was postulated by Tada and Okumura (34, 35) to be responsible 
for the 7S antibody-induced inhibition of hapten-specific IgE antibody produc- 
tion by rats  in vivo (34).  Ishizaka and Okudaira  (36),  however, reported that 
anti-EA  IgG  antibody  failed  to  depress  anti-EA  IgE  antibody  responses  in 
mice. In the in vitro experiments reported here, endogenous production of one 
class of antibody (e.g., IgM or IgG) did not seem to play a role in the regulation 
of the IgE class of antibody. The fact that EA alone enhanced anti-DNP IgM/ 1546  REGULATION  OF  REAGINIC  ANTIBODY  PRODUCTION  IN  MICE 
IgG immune responses in vitro but had no detectable effect on the spontaneous 
anti-DNP IgE response, and the fact that DNP-BGG had no effect on the anti- 
DNP IgM/IgG secondary immune response in vitro but suppressed anti-DNP 
IgE  production,  suggest  that  the  IgE  antibody  response  in  vitro  was  not 
regulated by endogenous production of anti-DNP antibodies of other Ig classes. 
Summary 
Regulation of IgE production by antigen in a primed murine splenic lympho- 
cyte culture  system  was  described.  Maximum  IgE  antibody  production  was 
found to occur when cells were cultured  in the absence of exogenously added 
antigen.  A  cells and T  lymphocytes did not affect the production of anti-DNP 
IgE antibody. 
By using  a  hapten-carrier  antigen  system  (DNP-EA)  for priming  mice  in 
vivo, it was found that the production of anti-DNP IgE by spleen cells in vitro 
was  inhibited  by hapten  when  coupled  to  homologous  (EA)  or heterologous 
(BGG) carrier, and was not enhanced or inhibited by homologous carrier. Anti- 
DNP  IgE  antibody  production  by  cultures  depleted  of  macrophages  or  T 
lymphocytes was found to be as sensitive to the suppressive effects of hapten as 
was the IgE production by whole spleen cell cultures. 
Both IgM and IgG secondary anti-DNP PFC responses in vitro were enhanced 
by the presence of the homologous hapten-carrier  or carrier  alone.  DNP-BGG 
had no effect on the anti-DNP IgM or IgG PFC responses of the cultures. These 
data  suggest that  endogenous  production  of antibody  (IgM  or  IgG)  was  not 
responsible for the observed suppression of the IgE response in vitro. 
The experimental  results presented  indicate that the regulation  of the IgE 
production by antigen in the primed mouse splenic lymphocyte cultures was a 
consequence of the direct interaction of hapten with IgE B cells. 
Received for publication 18 July 1977. 
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